Tue, June 25, 2024
Mon, June 24, 2024
Fri, June 21, 2024
Thu, June 20, 2024
Wed, June 19, 2024
Tue, June 18, 2024

Matt O"Brien Maintained (TMDX) at Buy and Held Target at $120 on, Jun 21st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-120-on-jun-21st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matt O"Brien of Piper Sandler, Maintained "TransMedics Group, Inc." (TMDX) at Buy and Held Target at $120 on, Jun 21st, 2024.

Matt has made no other calls on TMDX in the last 4 months.

There are 6 other peers that have a rating on TMDX. Out of the 6 peers that are also analyzing TMDX, 1 agrees with Matt"s Rating of Hold. Following is the relevant analyst calls for the last 4 months;

Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $95 on, Wednesday, February 28th, 2024

These are the ratings of the 5 analyists that currently disagree with Matt;

Joshua Jennings of "TD Cowen" Maintained at Strong Buy with Increased Target to $175 on, Friday, June 7th, 2024
George Sellers of "Stephens & Co." Initiated at Buy and Held Target at $151 on, Tuesday, June 4th, 2024
Jason Mills of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $117 on, Wednesday, May 1st, 2024
Allen Gong of "JP Morgan" Maintained at Buy with Increased Target to $127 on, Wednesday, May 1st, 2024
Suraj Kalia of "Oppenheimer" Maintained at Buy with Increased Target to $125 on, Wednesday, May 1st, 2024


Publication Contributing Sources